Skip to main content
Erschienen in: Journal of General Internal Medicine 7/2021

26.04.2021 | Original Research

The Role of Physician Professional Networks in Physicians’ Receipt of Pharmaceutical and Medical Device Industries’ Payments

verfasst von: Aaron N. Winn, PhD, MPP, Aaron P. Mitchell, MD, MPH, Nicole Fergestrom, MS, Joan M. Neuner, MD, MPH, Justin G. Trogdon, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Financial relationships between physicians and the pharmaceutical and medical device industries are common, but the factors associated with physicians receiving payments are unknown.

Objective

The objective of this study is to evaluate the influence of physicians’ professional networks’ characteristics on the receipt of payments among physicians.

Design

Network analysis of cross-sectional data

Participants

US physicians who shared Medicare patients with other physicians in 2015 (N=357,813).

Exposure (Intervention)

Proportion of a physician’s professional network that received industry payments and other network characteristics including number of physician connections, how central the physician is within the network, and the tightness of the referral network in which a physician is located.

Main Outcome Measures

Relative risk of receiving industry payments. We used modified Poisson regression to control for confounding by gender, time since graduation, practice size, and practice setting (teaching hospital vs. not). We included dummy variables for specialty and hospital referral region level.

Key Results

The proportion of a physician’s peers in their professional network that received payments was strongly associated with receipt of pharmaceutical or device industry payments by the physician (top vs bottom quartile aRR=1.28, 95%CI=1.25–1.31). Physician’s centrality within a network had a small positive effect on receiving payment (top vs bottom quartile aRR=1.02, 95%CI=1.01–1.04). Network density also had a small negative association with receipt of payment (top vs bottom quartile aRR=0.97, 95%CI=0.96–0.98).

Conclusions

Network characteristics, particularly the receipt of payments among physicians one shares patients with, are associated with whether a physician receives payments. This finding has implications for institutional regulation of industry payments to physicians and demonstrates how institutional policy may impact not only the physicians within the institution but also physicians outside of the institution.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lo B, Field MJ (eds) Conflict of Interest in Medical Research, Education, and Practice. Washington (DC); 2009. Lo B, Field MJ (eds) Conflict of Interest in Medical Research, Education, and Practice. Washington (DC); 2009.
2.
Zurück zum Zitat Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ. Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med. 2006;355(22):2330-2337.CrossRef Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ. Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med. 2006;355(22):2330-2337.CrossRef
3.
Zurück zum Zitat Rose SL, Sah S, Dweik R, Schmidt C, Mercer M, Mitchum A, et al. Patient responses to physician disclosures of industry conflicts of interest: A randomized field experiment. Organ Behav Hum Decis Process. 2019. Rose SL, Sah S, Dweik R, Schmidt C, Mercer M, Mitchum A, et al. Patient responses to physician disclosures of industry conflicts of interest: A randomized field experiment. Organ Behav Hum Decis Process. 2019.
4.
Zurück zum Zitat Lerner TG, Miranda Mda C, Lera AT, Ueda A, Briones B, Del Giglio A, et al. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemp Clin Trials. 2012;33(5):1019-1022.CrossRef Lerner TG, Miranda Mda C, Lera AT, Ueda A, Briones B, Del Giglio A, et al. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemp Clin Trials. 2012;33(5):1019-1022.CrossRef
5.
Zurück zum Zitat Tibau A, Bedard PL, Srikanthan A, Ethier JL, Vera-Badillo FE, Templeton AJ, et al. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. J Clin Oncol 2015;33(1):100-106.CrossRef Tibau A, Bedard PL, Srikanthan A, Ethier JL, Vera-Badillo FE, Templeton AJ, et al. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. J Clin Oncol 2015;33(1):100-106.CrossRef
6.
Zurück zum Zitat Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373-380.CrossRef Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373-380.CrossRef
7.
Zurück zum Zitat Lieb K, Scheurich A. Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits. PLoS One. 2014;9(10):e110130.CrossRef Lieb K, Scheurich A. Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits. PLoS One. 2014;9(10):e110130.CrossRef
8.
Zurück zum Zitat Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med. 2010;7(10):e1000352.CrossRef Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med. 2010;7(10):e1000352.CrossRef
9.
Zurück zum Zitat DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Intern Med. 2016;176(8):1114-1122.CrossRef DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Intern Med. 2016;176(8):1114-1122.CrossRef
10.
Zurück zum Zitat Perlis RH, Perlis CS. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs. PLoS One. 2016;11(5):e0155474.CrossRef Perlis RH, Perlis CS. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs. PLoS One. 2016;11(5):e0155474.CrossRef
11.
Zurück zum Zitat Mitchell AP, Winn AN, Dusetzina SB. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries. JAMA Intern Med. 2018;178(6):854-856.CrossRef Mitchell AP, Winn AN, Dusetzina SB. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries. JAMA Intern Med. 2018;178(6):854-856.CrossRef
13.
Zurück zum Zitat Inoue K, Blumenthal DM, Elashoff D, Tsugawa Y. Association between physician characteristics and payments from industry in 2015-2017: observational study. BMJ Open. 2019;9(9):e031010.CrossRef Inoue K, Blumenthal DM, Elashoff D, Tsugawa Y. Association between physician characteristics and payments from industry in 2015-2017: observational study. BMJ Open. 2019;9(9):e031010.CrossRef
14.
Zurück zum Zitat Tringale KR, Hattangadi-Gluth JA. Types and Distributions of Biomedical Industry Payments to Men and Women Physicians by Specialty, 2015. JAMA Intern Med. 2018;178(3):421-423.CrossRef Tringale KR, Hattangadi-Gluth JA. Types and Distributions of Biomedical Industry Payments to Men and Women Physicians by Specialty, 2015. JAMA Intern Med. 2018;178(3):421-423.CrossRef
15.
Zurück zum Zitat Landon BE, Keating NL, Barnett ML, Onnela JP, Paul S, O'Malley AJ, et al. Variation in patient-sharing networks of physicians across the United States. JAMA. 2012;308(3):265-273.CrossRef Landon BE, Keating NL, Barnett ML, Onnela JP, Paul S, O'Malley AJ, et al. Variation in patient-sharing networks of physicians across the United States. JAMA. 2012;308(3):265-273.CrossRef
16.
Zurück zum Zitat Barnett ML, Christakis NA, O'Malley J, Onnela JP, Keating NL, Landon BE. Physician patient-sharing networks and the cost and intensity of care in US hospitals. Med Care. 2012;50(2):152-160.CrossRef Barnett ML, Christakis NA, O'Malley J, Onnela JP, Keating NL, Landon BE. Physician patient-sharing networks and the cost and intensity of care in US hospitals. Med Care. 2012;50(2):152-160.CrossRef
17.
Zurück zum Zitat Casalino LP, Pesko MF, Ryan AM, Nyweide DJ, Iwashyna TJ, Sun X, et al. Physician Networks and Ambulatory Care-sensitive Admissions. Med Care. 2015;53(6):534-541.CrossRef Casalino LP, Pesko MF, Ryan AM, Nyweide DJ, Iwashyna TJ, Sun X, et al. Physician Networks and Ambulatory Care-sensitive Admissions. Med Care. 2015;53(6):534-541.CrossRef
20.
Zurück zum Zitat Wennberg J, Gittelsohn. Small area variations in health care delivery. Science. 1973;182(4117):1102-1108.CrossRef Wennberg J, Gittelsohn. Small area variations in health care delivery. Science. 1973;182(4117):1102-1108.CrossRef
21.
Zurück zum Zitat Fisher ES. Dartmouth Atlas of Health Care- Hospital Referral Region. Lebanon, NH: Dartmouth Institute for Health Policy and Clinical Practice; 2019. Fisher ES. Dartmouth Atlas of Health Care- Hospital Referral Region. Lebanon, NH: Dartmouth Institute for Health Policy and Clinical Practice; 2019.
22.
Zurück zum Zitat Freeman LC. Centrality in Social Networks conceptual clarification. Soc Netw. 1979;1(3):215-239.CrossRef Freeman LC. Centrality in Social Networks conceptual clarification. Soc Netw. 1979;1(3):215-239.CrossRef
23.
Zurück zum Zitat Newman MEJ. The structure and function of complex networks. Siam Rev. 2003;45(2):167-256.CrossRef Newman MEJ. The structure and function of complex networks. Siam Rev. 2003;45(2):167-256.CrossRef
24.
Zurück zum Zitat Goldsmith-Pinkham P, Imbens GW. Social Networks and the Identification of Peer Effects. J Bus Econ Stat. 2013;31(3):253-264.CrossRef Goldsmith-Pinkham P, Imbens GW. Social Networks and the Identification of Peer Effects. J Bus Econ Stat. 2013;31(3):253-264.CrossRef
25.
Zurück zum Zitat Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J. 2012;12(2):308-331.CrossRef Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J. 2012;12(2):308-331.CrossRef
26.
Zurück zum Zitat Manski CF. Identification of endogenous social effects: The reflection problem. Rev Econ Stud. 1993;60(3):531-542.CrossRef Manski CF. Identification of endogenous social effects: The reflection problem. Rev Econ Stud. 1993;60(3):531-542.CrossRef
27.
Zurück zum Zitat Bramoulle Y, Djebbari H, Fortin B. Identification of peer effects through social networks. J Econ. 2009;150(1):41-55.CrossRef Bramoulle Y, Djebbari H, Fortin B. Identification of peer effects through social networks. J Econ. 2009;150(1):41-55.CrossRef
28.
Zurück zum Zitat Ahn T, Trogdon JG. Peer delinquency and student achievement in middle school. Labour Econ. 2017;44:192-217.CrossRef Ahn T, Trogdon JG. Peer delinquency and student achievement in middle school. Labour Econ. 2017;44:192-217.CrossRef
29.
Zurück zum Zitat Terza J, Basu A, Rathouz P. Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling. J Health Econ. 2008;27(3):12.CrossRef Terza J, Basu A, Rathouz P. Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling. J Health Econ. 2008;27(3):12.CrossRef
30.
Zurück zum Zitat Mitchell AP, Lund JL, Winn AN, Dusetzina SB. Evaluating the Strength of the Association Between Industry Payments and Prescribing in Oncology. The Oncologist. 2019;Accepted. Mitchell AP, Lund JL, Winn AN, Dusetzina SB. Evaluating the Strength of the Association Between Industry Payments and Prescribing in Oncology. The Oncologist. 2019;Accepted.
31.
Zurück zum Zitat Anderson TS, Good CB, Gellad WF. Industry Payments to Academic Physicians: a Comparison of Reporting to Two Government Agencies. J Gen Intern Med. 2018;33(10):1604-1606.CrossRef Anderson TS, Good CB, Gellad WF. Industry Payments to Academic Physicians: a Comparison of Reporting to Two Government Agencies. J Gen Intern Med. 2018;33(10):1604-1606.CrossRef
32.
Zurück zum Zitat Onnela JP, O’Malley AJ, Keating NL, Landon BE. Comparison of physician networks constructed from thresholded ties versus shared clinical episodes. Appl Netw Sci. 2018;3(1):28.CrossRef Onnela JP, O’Malley AJ, Keating NL, Landon BE. Comparison of physician networks constructed from thresholded ties versus shared clinical episodes. Appl Netw Sci. 2018;3(1):28.CrossRef
33.
Zurück zum Zitat Donohue JM, Guclu H, Gellad WF, Chang CH, Huskamp HA, Choudhry NK, et al. Influence of peer networks on physician adoption of new drugs. PLoS One. 2018;13(10):e0204826.CrossRef Donohue JM, Guclu H, Gellad WF, Chang CH, Huskamp HA, Choudhry NK, et al. Influence of peer networks on physician adoption of new drugs. PLoS One. 2018;13(10):e0204826.CrossRef
34.
Zurück zum Zitat Barnett ML, Landon BE, O'Malley AJ, Keating NL, Christakis NA. Mapping physician networks with self-reported and administrative data. Health Serv Res. 2011;46(5):1592-1609.CrossRef Barnett ML, Landon BE, O'Malley AJ, Keating NL, Christakis NA. Mapping physician networks with self-reported and administrative data. Health Serv Res. 2011;46(5):1592-1609.CrossRef
Metadaten
Titel
The Role of Physician Professional Networks in Physicians’ Receipt of Pharmaceutical and Medical Device Industries’ Payments
verfasst von
Aaron N. Winn, PhD, MPP
Aaron P. Mitchell, MD, MPH
Nicole Fergestrom, MS
Joan M. Neuner, MD, MPH
Justin G. Trogdon, PhD
Publikationsdatum
26.04.2021
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 7/2021
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-021-06802-9

Weitere Artikel der Ausgabe 7/2021

Journal of General Internal Medicine 7/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.